Table 4.
HR (95% CI) for incident AMI according to urinary Hcy‐thiolactone/creatinine
| HR (95% CI) for each tertile of urinary Hcy‐thiolactone/creatinine | P trend | HR (95% CI) per one SD increment | |||
|---|---|---|---|---|---|
| T1 | T2 | T3 | |||
| Patients, n | 683 | 685 | 679 | ||
| AMI events, n (%) | 53 (7.8) | 58 (8.5) | 72 (10.5) | ||
| Model 1a | 1 | 1.14 (0.78–1.65) | 1.59 (1.11–2.27) | 0.011 | 1.22 (1.05–1.42) |
| Model 2b | 1 | 1.17 (0.81–1.70) | 1.58 (1.10–2.26) | 0.012 | 1.22 (1.05–1.41) |
| Model 3c | 1 | 1.16 (0.81–1.69) | 1.58 (1.10–2.26) | 0.012 | 1.22 (1.05–1.41) |
SD, standard deviation; HR, hazard ratio; CI, confidence interval.
aAdjusted for age and gender. bAdjusted for age, gender, hypertension, diabetes, smoking, extent of CAD at angiography and LVEF. cAdjusted for variables in Model 2 plus medications at discharge (including statins, β‐blockers and angiotensin converting enzyme inhibitors and/or angiotensin receptor blocker).